Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOGENIC NORGE AS
AS
Active
Org 831184752
Brannstasjonsveien 8, 4312 Sandnes
Computer programming activities · NACE 6210
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 4,6M
+26% vs 2024
EBITDA margin
-1.3%
-124% vs 2024
Equity ratio
19.6%
Financial strength
Net profit 2025
NOK -78K
-141% vs 2024
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 4,6M
+26%
EBITDA
NOK -59K
-124%
Net profit
NOK -78K
-141%
Total assets
NOK 2,1M
+193%
Equity
NOK 413K
-16%
Employees
0
—
Company information
Legal name
BIOGENIC NORGE AS
Org number
831184752
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
12. april 2023
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Levere teknologi og løsninger rettet mot biogass og energianlegg.
Contact
Address
Brannstasjonsveien 8, 4312 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer programming activities
Companies in Sandnes
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
3M
2023
4M
2024
5M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
2 938
3 654
4 615
Staff expenses
−0
−28
−108
EBITDA
354
250
−59
Depreciation & amort.
−0
−0
−0
EBIT
354
250
−59
Net financials
−96
−7
−19
Profit before tax
259
243
−78
Tax
57
54
−0
Net profit
202
189
−78
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
3 066
716
2 101
Equity
302
491
413
Long-term debt
0
0
0
Short-term debt
2 764
225
1 688
Total debt
2 764
225
1 688
Financial ratios
5-year trend
EBITDA margin
-1.3%
This company
15.8%
Market median
-108% vs market
2023
2025
Equity ratio
19.6%
This company
38.2%
Market median
-49% vs market
2023
2025
Return on equity
-19.0%
This company
18.4%
Market median
-203% vs market
2023
2025
Net profit margin
-1.7%
This company
8.1%
Market median
-121% vs market
2023
2025
Asset turnover
2.20×
This company
1.12×
Market median
+96% vs market
2023
2025
Debt / equity
4.09×
This company
0.62×
Market median
-560% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
CN
Christian Nøttveit
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
HL
Harry Leo Nøttveit
Chairman
2023
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIOGENIC NORGE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Christian Nøttveit
Chief Executive Officer
0 companies
Harry Leo Nøttveit
Chairman
0 companies